Cargando…

Demyelinating polyneuropathy combined with brachial plexopathy after nivolumab therapy for hodgkin lymphoma: a case report

BACKGROUND: Nivolumab is an immune checkpoint inhibitor that targets the programmed cell death-1 protein and is effective in treating advanced cancer. However, it is also associated with various immune-related neurological complications, including myasthenia gravis, Guillain–Barré syndrome, and demy...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Chulmin, Kim, Kyoung Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10061856/
https://www.ncbi.nlm.nih.gov/pubmed/36997886
http://dx.doi.org/10.1186/s12883-023-03177-8